Houlihan Lokey (HLI) reported $511 million in revenue for the quarter ended June 2026, representing a year-over-year decline of 15.6%. EPS of $1.35 for the same period compares to $2.14 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $602.55 million, representing a surprise of -15.19%. The company delivered an EPS surprise of -17.68%, with the consensus EPS estimate being $1.64.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Houlihan Lokey performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenues- Corporate Finance: $303 million versus $388.54 million estimated by two analysts on average.
  • Revenues- Financial and Valuation Advisory: $89 million compared to the $82.55 million average estimate based on two analysts.
  • Revenues- Financial Restructuring: $119 million versus $128.99 million estimated by two analysts on average.

View all Key Company Metrics for Houlihan Lokey here>>>

Shares of Houlihan Lokey have returned +8.5% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

Houlihan Lokey, Inc. (HLI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research